Page last updated: 2024-09-05

erlotinib hydrochloride and Rhabdomyolysis

erlotinib hydrochloride has been researched along with Rhabdomyolysis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badovinac, S; Božina, N; Čučević, B; Jakopović, M; Koršić, M; Muršić, D; Roglić, M	1
Sundermeyer, M; Veeraputhiran, M	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Rhabdomyolysis

Article	Year
Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:6 Topics: ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Non-Small-Cell Lung; Cytochrome P-450 CYP2C19; Drug Interactions; Erlotinib Hydrochloride; Female; Homozygote; Humans; Lung Neoplasms; Middle Aged; Pharmacogenetics; Protein Kinase Inhibitors; Rhabdomyolysis	2015
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin. Clinical lung cancer, 2008, Volume: 9, Issue:4 Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed	2008

Article

Year

Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:6

Topics: ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Non-Small-Cell Lung; Cytochrome P-450 CYP2C19; Drug Interactions; Erlotinib Hydrochloride; Female; Homozygote; Humans; Lung Neoplasms; Middle Aged; Pharmacogenetics; Protein Kinase Inhibitors; Rhabdomyolysis

2015

Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.

Clinical lung cancer, 2008, Volume: 9, Issue:4

Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed

2008